J. Maier

Cardiac troponin I in the diagnosis of myocardial injury and infarction.

E Ambach, P. Mair, J. Mair, 1996, Clinica chimica acta; international journal of clinical chemistry.

Rebound increase of plasminogen activator inhibitor type I after cessation of thrombolytic treatment for acute myocardial infarction is independent of type of plasminogen activator used.

J. Mair, B. Puschendorf, P. Lechleitner, 1998, Clinical chemistry.

Plasma immunoreactive endothelin in the acute and subacute phases of myocardial infarction in patients undergoing fibrinolysis.

J. Mair, B. Puschendorf, P. Lechleitner, 1993, Clinical chemistry.

PlasmaImmunoreactive Endothelinin the Acuteand SubacutePhasesof Myocardial Infarctionin PatientsUndergoingFibrinolysis

J. Mair, B. Puschendorf, P. Lechleitner, 1993 .

Markers of activated coagulation for early diagnosis of acute myocardial infarction.

J. Mair, B. Puschendorf, P. Lechleitner, 1997, Clinica chimica acta; international journal of clinical chemistry.

Endothelin-1 in patients with complicated and uncomplicated myocardial infarction

J. Mair, B. Puschendorf, P. Lechleitner, 1992, The clinical investigator.

Thrombin generation during infusion of tissue-type plasminogen activator

J. Mair, B. Puschendorf, P. Lechleitner, 1993, The Lancet.